2015 Conquer Cancer Foundation of ASCO Young Investigator Award Funded by Kidney Cancer Association
Matthew Campbell, MD
Chief Fellow, Hematology/Oncology Fellowship, UT MD Anderson Cancer Center
New agents called immune check point inhibitors have been FDA approved in the treatment of metastatic melanoma and metastatic squamous cell lung cancer. These agents have shown exciting activity in bladder, kidney, and a variety of other cancers in early clinical studies and are being explored in larger studies. The first of these agents, ipilimumab, is an antibody that binds to CTLA-4, a molecule that is increased by T cells responding to a stimulus, to help shut off the immune response. When the ...
Source: Kidney Cancer Association - May 11, 2015 Category: Cancer & Oncology Source Type: news
2015 Conquer Cancer Foundation of ASCO Young Investigator Award Funded by Kidney Cancer Association
Matthew Campbell, MD
Chief Fellow, Hematology/Oncology Fellowship, UT MD Anderson Cancer CenterNew agents called immune check point inhibitors have been FDA approved in the treatment of metastatic melanoma and metastatic squamous cell lung cancer. These agents have shown exciting activity in bladder, kidney, and a variety of other cancers in early clinical studies and are being explored in larger studies. The first of these agents, ipilimumab, is an antibody that binds to CTLA-4, a molecule that is increased by T cells responding to a stimulus, to help shut off the immune response. When the an...
Source: Kidney Cancer Association - May 11, 2015 Category: Urology & Nephrology Source Type: news
2015 Conquer Cancer Foundation of ASCO Young Investigator Award Funded by Kidney Cancer Association
Matthew Campbell, MD
Chief Fellow, Hematology/Oncology Fellowship, UT MD Anderson Cancer Center
New agents called immune check point inhibitors have been FDA approved in the treatment of metastatic melanoma and metastatic squamous cell lung cancer. These agents have shown exciting activity in bladder, kidney, and a variety of other cancers in early clinical studies and are being explored in larger studies. The first of these agents, ipilimumab, is an antibody that binds to CTLA-4, a molecule that is increased by T cells responding to a stimulus, to help shut off the immune response. When the ...
Source: Kidney Cancer Association - May 11, 2015 Category: Urology & Nephrology Source Type: news
2015 Conquer Cancer Foundation of ASCO Young Investigator Award
Layperson Summary
New agents called immune check point inhibitors have been FDA approved in the treatment of metastatic melanoma and metastatic squamous cell lung cancer. These agents have shown exciting activity in bladder, kidney, and a variety of other cancers in early clinical studies and are being explored in larger studies. The first of these agents, ipilimumab, is an antibody that binds to CTLA-4, a molecule that is increased by T cells responding to a stimulus, to help shut off the immune response. When the anti-body binds to CTLA-4, the immune system is able to stay activated an...
Source: Kidney Cancer Association - May 10, 2015 Category: Cancer & Oncology Source Type: news
Adding ingenol mebutate after cryosurgery enhances clearance of actinic keratoses
Read the full story on MD Consult:
Adding ingenol mebutate after cryosurgery enhances clearance of actinic keratoses (Source: MD Consult: News: Top Stories)
Source: MD Consult: News: Top Stories - July 21, 2014 Category: Journals (General) Source Type: news
Cryoablation and nanoparticle-encapsulated anticancer drug combined to destroy cancer stem-like cells
Combining nanodrug-based chemotherapy and cryoablation provides an effective strategy to eliminate cancer stem-like cells (CSCs) the root of cancer resistance and metastasis, which will help to improve the safety and efficacy of treating malignancies that are refractory to conventional therapies.Cryoablation (also called cryosurgery or cryotherapy) is an energy-based, minimally invasive surgical technique that has been investigated to treat a variety of diseases including cancer, which is done by freezing the diseased tissue to subzero temperature to induce irreversible damage. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 16, 2014 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news
Cancer stem cells destroyed with cryoablation and nanoparticle-encapsulated anticancer drug
Combining nanodrug-based chemotherapy and cryoablation provides an effective strategy to eliminate cancer stem-like cells -- the root of cancer resistance and metastasis, which will help to improve the safety and efficacy of treating malignancies that are refractory to conventional therapies. Cryoablation (also called cryosurgery or cryotherapy) is an energy-based, minimally invasive surgical technique that has been investigated to treat a variety of diseases including cancer, which is done by freezing the diseased tissue to subzero temperature to induce irreversible damage. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 13, 2014 Category: Science Source Type: news
LEO Pharma announce the completion of the Phase III FIELD Study 1, evaluating one year treatment outcomes of actinic keratosis
LEO Pharma has announced the completion of the Phase III FIELD Study 1 - the largest[1-3] ever, one year evaluation of field treatment with ingenol mebutate gel for actinic keratosis (AK) after initial cryosurgery of individual AK lesions, compared to cryosurgery followed by a vehicle gel. The study involved more than 300 patients across 35 trial sites and is also the first to evaluate field treatment with ingenol mebutate gel subsequent to cryosurgery. LEO Pharma reported that the study met its efficacy and safety endpoints at 11 weeks and 12 months... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 30, 2013 Category: Consumer Health News Tags: Dermatology Source Type: news
VIDEO: Non-Surgical Treatment of Kidney Cancer
Dr. Kamran Ahmar of the M.D. Anderson Cancer Center in Houston, Texas, discusses the use of two methods of dealing with kidney tumors that can be done with tiny probes inserted through the skin guided by imaging to destroy the tumor tissue -- Radio frequency ablation (using heat) and cryosurgery (using freezing).04/23/2011 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - April 23, 2011 Category: Urology & Nephrology Source Type: news
